OCLG Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume150.17K
Average Volume (3M)N/A
Market Cap
$166.25K
Enterprise Value$73.66K
Total Cash (Recent Filing)$4.85K
Total Debt (Recent Filing)$23.62K
Price to Earnings (P/E)―
Beta-14.75
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,662,469,200
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.04
Price to Sales (P/S)0.08
P/FCF Ratio-8.80
Enterprise Value/Market Cap0.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-3.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OCLG FAQ
What was Oncologix Tech Inc’s price range in the past 12 months?
Oncologix Tech Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Oncologix Tech Inc’s market cap?
Oncologix Tech Inc’s market cap is $166.25K.
When is Oncologix Tech Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oncologix Tech Inc’s earnings last quarter?
Currently, no data Available
Is Oncologix Tech Inc overvalued?
According to Wall Street analysts Oncologix Tech Inc’s price is currently Overvalued.
Does Oncologix Tech Inc pay dividends?
Oncologix Tech Inc does not currently pay dividends.
What is Oncologix Tech Inc’s EPS estimate?
Oncologix Tech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncologix Tech Inc have?
Oncologix Tech Inc has 1,662,469,200 shares outstanding.
What happened to Oncologix Tech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oncologix Tech Inc?
Currently, no hedge funds are holding shares in OCLG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Oncologix Tech Inc
Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in personal home care services and the manufacturing and distribution of medical technologies. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007.
Technical Analysis
NetCapital
―
Sentage Holdings
―
Beneficient
―
Magic Empire Global Ltd.
―
Pineapple Financial
―